- Allergan Issues Statement on Namenda XR Patent Litation Following.
- Takeda Wins Patent Infringement Litation on Appeal against ANDA.
- Here Comes The Tidal Wave of Generic DJ Actions - Axinn, Veltrop.
- Detterick found the porch em Just another site
Allergan Issues Statement on Namenda XR Patent Litation Following.
EDITORIAL NOTE: On September 30, 2014, Steve Moore will participate in a webcast with Omar Jabri, Senior Patent Counsel, Global Intellectual Property, at Apotex, and Owen Byrd, General Counsel of Lex Machina, on the new ANDA-specific capabilities of Lex Machina’s Legal Analytics platform. _______________ Lex Machina (emphasize the “Mach” followed by “ina”) is a legal technology platform that emerged from a collaboration between experts at Stanford’s Computer Science Department and Law School.
Takeda Wins Patent Infringement Litation on Appeal against ANDA.
Litation of mass torts or product liability claims often have an international component, as one or more of the defendants involved may be outside the US.
Here Comes The Tidal Wave of Generic DJ Actions - Axinn, Veltrop.
« Sandoz's Motion for Preliminary Injunction to Delay FDA Approval of Generic Zocor is Denied | Main | FTC Commissioner Testifies on Barriers to Generic Market Entry Before Senate Special Committee on Aging » The U. District Court for the District of Delaware released its opinion last Thursday in the Lexapro patent infringement case, finding in favor of Forest Labs.
Detterick found the porch em Just another site
, the Federal Circuit held that the district court had jurisdiction over Astra Zeneca’s ANDA complaint, but also held that the complaint should be dismissed for failing to state a viable claim for relief because the ANDAs included Section viii statements that carved out the methods claimed in the patents at issue. So is filing an ANDA seeking to market an unpatented drug for an unpatented use beyond the scope of § 271(e)(2).
Lexapro anda patent litigation:
Rating: 88 / 100
Overall: 89 Rates